IPSC logo

IPSC
Century Therapeutics Inc

720
Mkt Cap
$404.38M
Volume
910,557.00
52W High
$3.04
52W Low
$0.435
PE Ratio
-21.37
IPSC Fundamentals
Price
$2.25
Prev Close
$2.26
Open
$2.26
50D MA
$2.18
Beta
1.54
Avg. Volume
1.64M
EPS (Annual)
-$0.1107
P/B
1.24
Rev/Employee
$1.4M
$11.76
Loading...
Loading...
News
all
press releases
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 13th, there was short interest totaling 8,626,834...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Moderate Buy" by Brokerages
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are currently covering the firm, Marketbeat...
MarketBeat·15d ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) SVP Douglas Carr sold 7,043 shares of the company's stock in a transaction on Thursday, March 12th. The stock was sold at an average price...
MarketBeat·26d ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Gregory Russotti sold 10,076 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was...
MarketBeat·26d ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Large Growth in Short Interest
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·27d ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Century Therapeutics (NASDAQ:IPSC - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus...
MarketBeat·29d ago
News Placeholder
Century Therapeutics (IPSC) to Release Quarterly Earnings on Wednesday
Century Therapeutics (NASDAQ:IPSC) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 18. (View Earnings Report at...
MarketBeat·1mo ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Raised to "Hold" at Wall Street Zen
Wall Street Zen upgraded Century Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, Marketbeat reports. One...
MarketBeat·1mo ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 39.8% in February
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) saw a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 4,739,771...
MarketBeat·1mo ago
<
1
2
...
>

Latest IPSC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.